Compass Therapeutics Inc. CMPX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
1.56UNCH (UNCH)
Volume
2,672
Close
1.56quote price arrow down-0.04 (-2.50%)
Volume
255,470
52 week range
1.15 - 3.62
Loading...
  • Open1.71
  • Day High1.71
  • Day Low1.41
  • Prev Close1.60
  • 52 Week High3.62
  • 52 Week High Date05/23/23
  • 52 Week Low1.15
  • 52 Week Low Date02/05/24

Key Stats

  • Market Cap214.639M
  • Shares Out137.59M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.72
  • YTD % Change-1.423362852083534e-14

KEY STATS

  • Open1.71
  • Day High1.71
  • Day Low1.41
  • Prev Close1.60
  • 52 Week High3.62
  • 52 Week High Date05/23/23
  • 52 Week Low1.15
  • 52 Week Low Date02/05/24
  • Market Cap214.639M
  • Shares Out137.59M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.72
  • YTD % Change-1.423362852083534e-14

RATIOS/PROFITABILITY

  • EPS (TTM)-0.33
  • P/E (TTM)-4.67
  • Fwd P/E (NTM)-3.25
  • EBITDA (TTM)-49.668M
  • ROE (TTM)-25.74%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Compass Therapeutics Inc.

 

Profile

MORE
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is developing proprietary antibody-based therapeutics to treat multiple human diseases. Its pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. Its lead product candidate, CTX-009, is a bispecific antibody targeting Delta-like ligand 4 (DLL4), a ligand of Notch-1, and vascular...
Thomas Schuetz M.D., Ph.D.
Vice Chairman of the Board and President of Research and Development
Carl Gordon Ph.D.
Independent Chairman of the Board
Vered Bisker-Leib Ph.D.
Chief Executive Officer, Director
Address
80 Guest Street
Boston, MA
02135
United States

Top Peers

SYMBOLLASTCHG%CHG
INMB
INmune Bio Inc
9.92-0.10-1.00%
ALDX
Aldeyra Therapeutics Inc
3.70-0.07-1.86%
OVID
Ovid Therapeutics Inc
3.02+0.02+0.67%
LYRA
Lyra Therapeutics Inc
0.3626-0.0099-2.6577%
TRVI
Trevi Therapeutics Inc
2.73UNCHUNCH